Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Cannabinoid, CB1 | 11 | 2019 | 41 | 1.840 |
Why?
|
| Endocannabinoids | 9 | 2022 | 41 | 1.180 |
Why?
|
| Asthma | 9 | 2022 | 416 | 1.080 |
Why?
|
| Arachidonic Acids | 6 | 2017 | 25 | 1.060 |
Why?
|
| Cannabinoids | 8 | 2022 | 73 | 1.020 |
Why?
|
| Ethanol | 4 | 2019 | 224 | 0.920 |
Why?
|
| Receptor, Cannabinoid, CB2 | 6 | 2018 | 38 | 0.800 |
Why?
|
| Polyunsaturated Alkamides | 5 | 2017 | 15 | 0.710 |
Why?
|
| Anti-Asthmatic Agents | 5 | 2021 | 44 | 0.660 |
Why?
|
| Neurogenesis | 2 | 2018 | 63 | 0.620 |
Why?
|
| Receptors, Cannabinoid | 6 | 2022 | 31 | 0.600 |
Why?
|
| Matrix Metalloproteinases | 2 | 2009 | 49 | 0.560 |
Why?
|
| Zebrafish | 2 | 2019 | 146 | 0.460 |
Why?
|
| Signal Transduction | 9 | 2019 | 2157 | 0.430 |
Why?
|
| Hippocampus | 1 | 2018 | 594 | 0.430 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 423 | 0.390 |
Why?
|
| GTP-Binding Proteins | 2 | 2002 | 59 | 0.370 |
Why?
|
| Nervous System | 1 | 2012 | 32 | 0.360 |
Why?
|
| Piperidines | 5 | 2022 | 83 | 0.320 |
Why?
|
| Neovascularization, Physiologic | 2 | 2009 | 80 | 0.300 |
Why?
|
| Pharmacogenetics | 2 | 2021 | 67 | 0.300 |
Why?
|
| Molecular Probes | 1 | 2009 | 23 | 0.300 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2007 | 13 | 0.290 |
Why?
|
| Animals | 20 | 2022 | 16992 | 0.280 |
Why?
|
| Endothelial Cells | 3 | 2009 | 329 | 0.280 |
Why?
|
| Pyrazoles | 4 | 2018 | 103 | 0.270 |
Why?
|
| Nitric Oxide | 2 | 2007 | 386 | 0.250 |
Why?
|
| Cyclic AMP | 1 | 2006 | 127 | 0.240 |
Why?
|
| Receptors, Drug | 2 | 2002 | 61 | 0.240 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2007 | 140 | 0.230 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 3 | 2022 | 55 | 0.230 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2021 | 64 | 0.230 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 239 | 0.220 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 1019 | 0.210 |
Why?
|
| Glycerides | 2 | 2017 | 12 | 0.200 |
Why?
|
| Stroke | 1 | 2007 | 340 | 0.200 |
Why?
|
| Muscle Relaxation | 1 | 2002 | 19 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 1596 | 0.190 |
Why?
|
| Macrophages | 1 | 2006 | 529 | 0.180 |
Why?
|
| Rats | 6 | 2018 | 3735 | 0.180 |
Why?
|
| Epoxide Hydrolases | 1 | 2021 | 8 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2022 | 863 | 0.180 |
Why?
|
| Cyclopropanes | 1 | 2021 | 46 | 0.180 |
Why?
|
| Child | 8 | 2021 | 3443 | 0.180 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2021 | 19 | 0.170 |
Why?
|
| Acetates | 1 | 2021 | 32 | 0.170 |
Why?
|
| Sulfides | 1 | 2021 | 78 | 0.170 |
Why?
|
| Quinolines | 1 | 2021 | 78 | 0.170 |
Why?
|
| Administration, Inhalation | 4 | 2021 | 92 | 0.150 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2019 | 10 | 0.150 |
Why?
|
| Hedgehog Proteins | 1 | 2019 | 54 | 0.150 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 29 | 0.150 |
Why?
|
| Cytidine Deaminase | 1 | 2019 | 36 | 0.150 |
Why?
|
| Embryo, Nonmammalian | 1 | 2019 | 59 | 0.140 |
Why?
|
| Amidohydrolases | 2 | 2022 | 12 | 0.140 |
Why?
|
| Humans | 20 | 2022 | 43102 | 0.140 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 55 | 0.140 |
Why?
|
| AIDS Dementia Complex | 1 | 2019 | 116 | 0.140 |
Why?
|
| Carbamates | 1 | 2018 | 13 | 0.140 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 34 | 0.140 |
Why?
|
| Naphthalenes | 3 | 2007 | 38 | 0.140 |
Why?
|
| Benzoxazines | 3 | 2007 | 47 | 0.140 |
Why?
|
| Morpholines | 3 | 2007 | 72 | 0.130 |
Why?
|
| Neuropeptides | 1 | 2018 | 64 | 0.130 |
Why?
|
| Drug Interactions | 1 | 2018 | 150 | 0.130 |
Why?
|
| Enzyme Inhibitors | 3 | 2022 | 458 | 0.130 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2015 | 95 | 0.130 |
Why?
|
| Male | 11 | 2022 | 23409 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 95 | 0.130 |
Why?
|
| Caspase 3 | 1 | 2018 | 227 | 0.130 |
Why?
|
| Piperazines | 1 | 2018 | 120 | 0.130 |
Why?
|
| Cells, Cultured | 3 | 2017 | 1621 | 0.130 |
Why?
|
| Pertussis Toxin | 3 | 2007 | 25 | 0.130 |
Why?
|
| Cell Death | 1 | 2018 | 278 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 300 | 0.130 |
Why?
|
| Mice | 8 | 2022 | 6644 | 0.120 |
Why?
|
| Genotype | 4 | 2021 | 800 | 0.120 |
Why?
|
| Child, Preschool | 4 | 2021 | 1546 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 561 | 0.120 |
Why?
|
| Young Adult | 6 | 2021 | 5080 | 0.110 |
Why?
|
| Research Design | 1 | 2017 | 385 | 0.110 |
Why?
|
| Female | 11 | 2022 | 24698 | 0.110 |
Why?
|
| Adolescent | 6 | 2021 | 6081 | 0.110 |
Why?
|
| Rabbits | 2 | 2007 | 278 | 0.110 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 269 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 69 | 0.110 |
Why?
|
| Endothelium, Vascular | 2 | 2009 | 263 | 0.100 |
Why?
|
| Up-Regulation | 3 | 2019 | 536 | 0.100 |
Why?
|
| HIV-1 | 1 | 2019 | 755 | 0.100 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2013 | 6 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 432 | 0.100 |
Why?
|
| G-Protein-Coupled Receptor Kinases | 1 | 2013 | 7 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2022 | 1869 | 0.100 |
Why?
|
| Arrestins | 1 | 2013 | 28 | 0.100 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2013 | 21 | 0.100 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2012 | 2 | 0.100 |
Why?
|
| Membrane Microdomains | 1 | 2012 | 53 | 0.090 |
Why?
|
| Cyclooxygenase 2 | 1 | 2012 | 107 | 0.090 |
Why?
|
| Neutrophils | 1 | 2013 | 145 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1455 | 0.090 |
Why?
|
| Cysteine | 1 | 2012 | 103 | 0.090 |
Why?
|
| Motor Neurons | 1 | 2012 | 90 | 0.090 |
Why?
|
| Neural Pathways | 1 | 2012 | 138 | 0.090 |
Why?
|
| Prosencephalon | 2 | 2012 | 37 | 0.090 |
Why?
|
| Cyclohexanols | 2 | 2007 | 11 | 0.080 |
Why?
|
| Neurons | 1 | 2017 | 1263 | 0.080 |
Why?
|
| Cell Line | 3 | 2012 | 1410 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2012 | 403 | 0.080 |
Why?
|
| Azirines | 1 | 2009 | 2 | 0.080 |
Why?
|
| Photoaffinity Labels | 1 | 2009 | 3 | 0.080 |
Why?
|
| Azides | 1 | 2009 | 10 | 0.070 |
Why?
|
| Synaptic Transmission | 2 | 2022 | 149 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2013 | 986 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 665 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2021 | 587 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 182 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2007 | 1180 | 0.070 |
Why?
|
| Angiostatins | 1 | 2007 | 2 | 0.070 |
Why?
|
| HIV Infections | 1 | 2022 | 2586 | 0.070 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2007 | 6 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 1542 | 0.070 |
Why?
|
| Resorcinols | 1 | 2007 | 4 | 0.070 |
Why?
|
| Leucine | 1 | 2007 | 31 | 0.070 |
Why?
|
| Benzofurans | 1 | 2007 | 22 | 0.060 |
Why?
|
| Guanylate Cyclase | 1 | 2007 | 21 | 0.060 |
Why?
|
| Cardiovascular Agents | 1 | 2007 | 24 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2006 | 20 | 0.060 |
Why?
|
| Cycloheximide | 1 | 2006 | 30 | 0.060 |
Why?
|
| Chromones | 1 | 2007 | 53 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 66 | 0.060 |
Why?
|
| Reactive Nitrogen Species | 1 | 2006 | 10 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2006 | 31 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 74 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2007 | 561 | 0.060 |
Why?
|
| Pregnancy | 1 | 2012 | 1772 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2007 | 189 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2007 | 321 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 306 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 299 | 0.060 |
Why?
|
| Microglia | 1 | 2006 | 208 | 0.050 |
Why?
|
| Adult | 4 | 2021 | 13872 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1124 | 0.050 |
Why?
|
| Ligands | 1 | 2005 | 388 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2007 | 876 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 532 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 12 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 2676 | 0.050 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2002 | 2 | 0.050 |
Why?
|
| Disease Progression | 2 | 2017 | 667 | 0.050 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2002 | 5 | 0.050 |
Why?
|
| Calcium Channels | 1 | 2002 | 73 | 0.050 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2002 | 36 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 137 | 0.050 |
Why?
|
| Capsaicin | 1 | 2002 | 28 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2002 | 49 | 0.050 |
Why?
|
| Leukotriene Antagonists | 1 | 2021 | 1 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 135 | 0.040 |
Why?
|
| Europe | 1 | 2021 | 115 | 0.040 |
Why?
|
| Age of Onset | 1 | 2021 | 114 | 0.040 |
Why?
|
| Aorta | 1 | 2002 | 198 | 0.040 |
Why?
|
| Pyridines | 1 | 2022 | 139 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 287 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2021 | 201 | 0.040 |
Why?
|
| Alleles | 1 | 2021 | 352 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2021 | 490 | 0.040 |
Why?
|
| Risk Factors | 2 | 2020 | 3994 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2002 | 638 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 734 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2019 | 159 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1063 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 485 | 0.030 |
Why?
|
| Quality of Life | 1 | 2022 | 616 | 0.030 |
Why?
|
| International Cooperation | 1 | 2017 | 52 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 780 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 863 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2017 | 164 | 0.030 |
Why?
|
| Middle Aged | 2 | 2021 | 12222 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 491 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2015 | 114 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 1009 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2017 | 972 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 945 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 1175 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2013 | 18 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2013 | 51 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3156 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2013 | 68 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 1604 | 0.020 |
Why?
|
| Wound Healing | 1 | 2013 | 88 | 0.020 |
Why?
|
| Lipoylation | 1 | 2012 | 17 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 139 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 237 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 209 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 456 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 1035 | 0.020 |
Why?
|
| Corneal Neovascularization | 1 | 2007 | 6 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2007 | 19 | 0.020 |
Why?
|
| Chorioallantoic Membrane | 1 | 2007 | 11 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 495 | 0.020 |
Why?
|
| Epitope Mapping | 1 | 2007 | 32 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2007 | 91 | 0.020 |
Why?
|
| Biomimetic Materials | 1 | 2007 | 24 | 0.020 |
Why?
|
| Mutation | 1 | 2012 | 1177 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2007 | 118 | 0.020 |
Why?
|
| Analgesics | 1 | 2007 | 55 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 182 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2007 | 258 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2007 | 57 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2007 | 33 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 127 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 206 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 423 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 388 | 0.010 |
Why?
|
| Cattle | 1 | 2007 | 498 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 694 | 0.010 |
Why?
|
| Drug Design | 1 | 2007 | 186 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 259 | 0.010 |
Why?
|
| Protein Binding | 1 | 2007 | 1082 | 0.010 |
Why?
|
| Brain | 1 | 2006 | 1472 | 0.010 |
Why?
|